Crossmark

In patients with suspected thrombotic thrombocytopenic purpura, what is the optimal time to therapeutic plasma exchange?

Crossref DOI link: https://doi.org/10.1016/j.htct.2025.106223

Published Print: 2026-01

Update policy: https://doi.org/10.1016/elsevier_cm_policy

Authors

Soares Ferreira Junior, Alexandre https://orcid.org/0000-0002-1256-1249
Sanborn, Kate https://orcid.org/0000-0001-5772-733X
Pinheiro Maux Lessa, Morgana

Gordee, Alexander

Kuchibhatla, Maragatha

Taylor, Allison O. https://orcid.org/0000-0001-8797-9853
Karafin, Matthew S.

Onwuemene, Oluwatoyosi A. https://orcid.org/0000-0001-7266-7101
Funding

Funding for this research was provided by:

American Society of Hematology

Bristol-Myers Squibb Foundation

National Institutes of Health
License Information

Text and Data Mining valid from 2026-01-01

Text and Data Mining valid from 2026-01-01

Version of Record valid from 2025-11-12
More Information

This article is maintained by: Elsevier

Article Title: In patients with suspected thrombotic thrombocytopenic purpura, what is the optimal time to therapeutic plasma exchange?

Journal Title: Hematology, Transfusion and Cell Therapy

CrossRef DOI link to publisher maintained version: https://doi.org/10.1016/j.htct.2025.106223

Content Type: article

Copyright: Published by Elsevier España, S.L.U. on behalf of Associação Brasileira de Hematologia, Hemoterapia e Terapia Celular.